Globus acquires Nevro for their spinal cord stimulation for $250M

In simple terms, Nevro Corp. focuses on developing and providing medical devices that help manage chronic pain. They are known for their HFX spinal cord stimulation (SCS) system, which involves implanting a device that sends electrical signals to the spinal cord to reduce pain. This technology is particularly used for conditions like chronic back pain and painful diabetic neuropathy, aiming to offer significant relief without the need for medication or surgery.

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device comp...


Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.